Jenny Ruiz

Jenny Ruiz

Auto-generated profile, based on publicly available information

Jenny Ruiz

Department of Pediatrics University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
LCLusha Cao
Lusha Cao
YHYuan‐Shung Huang
Yuan‐Shung Huang
CWChao Wu
Chao Wu
KGKelly Getz
Kelly Getz
TMTamara P. Miller
Tamara P. Miller
YLYimei Li
Yimei Li

18 June 2024 in JNCI Cancer Spectrum
Verified
Journal Article
Open access
PDF file
MBMelissa P Beauchemin
Melissa P Beauchemin
MOMaria Ortega
Maria Ortega
SSSheila J Santacroce
Sheila J Santacroce
JRJoanna M Robles
Joanna M Robles
JRJenny Ruiz
Jenny Ruiz
MVMaria C Velez
Maria C Velez
Background: Persons who speak languages other than English are underrepresented in clinical trials, likely in part because of inadequate multilevel resources. We conducted a survey of institutions affiliated with the Children’s Oncology Group (COG) to characterize current research recruitment practices and resources regarding translation and interpretation services. Methods: In October 2022, a 20-item survey was distributed electronically to institutions affiliated with COG to assess consent practices and resources for recruiting participants who speak languages other than English to COG trials. Descriptive statistics were used to summarize responses; responses were compared by institution size and type as well as respondent role. Results: The survey was sent to 230 institutions, and the response rate was 60% (n = 139). In total, 60% (n = 83) of those respondents had access to short-form consent forms. Full consent form translation was required at 50% of institutions, and 12% of institutional review boards restricted use of centrally translated consent forms. Forty-six percent (n = 64) of institutions reported insufficient funding to support translation costs; 19% (n = 26) had access to no-cost translation services. Forty-four percent (n = 61) were required to use in-person interpreters for consent discussions; the most frequently cited barrier (56%) to obtaining consent was lack of available in-person interpreters. Forty-seven percent (n = 65) reported that recruiting persons who speak languages other than English to clinical trials was somewhat or very difficult. Conclusions: Institutions affiliated with COG face resource-specific challenges that impede recruitment of participants who speak languages other than English for clinical trials. These findings indicate an urgent need to identify strategies aimed at reducing recruitment barriers to ensure equitable access to clinical trials.

25 September 2024 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
JRJoanna M. Robles
Joanna M. Robles
JRJenny Ruiz
Jenny Ruiz
RCRamon Correa
Ramon Correa
NDNicole Dinescu‐Munoz
Nicole Dinescu‐Munoz
CPChandni Patel
Chandni Patel
TLThomas W. LeBlanc
Thomas W. LeBlanc

5 September 2024 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
SSSheila Judge Santacroce
Sheila Judge Santacroce
MBMelissa P. Beauchemin
Melissa P. Beauchemin
WPWendy Pelletier
Wendy Pelletier
JRJoanna M. Robles
Joanna M. Robles
JRJenny Ruiz
Jenny Ruiz
LWLena Winestone
Lena Winestone

14 January 2025 in Pediatric Blood & Cancer
Verified
Journal Article
Open access
JRJenny Ruiz
Jenny Ruiz
JRJoanna M. Robles
Joanna M. Robles
LSLuisanna M. Sánchez
Luisanna M. Sánchez
AKAlisa Khan
Alisa Khan
ALAmy D. Lu
Amy D. Lu
PAPaula Aristizabal
Paula Aristizabal
Language‐discordant healthcare encounters—when the patient/caregiver and clinician are not able to communicate directly in the patient's/caregiver's preferred language—are associated with worse quality of care, increased adverse events, and research exclusion. Here, we describe the current state of language justice in clinical practice and research in the United States, Canada, and Spain, discuss the role of social determinants of health and language in patient safety and health outcomes, and review an example of culturally and linguistically concordant interventions to increase research participation. We close with practical and global strategies to increase multilingual research participation and to provide equitable patient‐ and family‐centered care in pediatric hematology‐oncology.

1 December 2018 in JCO Clinical Cancer Informatics
Verified
Journal Article
Closed access
FVFernando S. Valencia
Fernando S. Valencia
RRRossana Ruiz
Rossana Ruiz
SNSilvia P. Neciosup
Silvia P. Neciosup
LMLuis A. Mas
Luis A. Mas
KAKarina M. Aliaga
Karina M. Aliaga
HGHenry Leonidas Gomez
Henry Leonidas Gomez
Purpose: We describe the implementation process of a computerized physician order entry (CPOE) for outpatient chemotherapy at a Latin American hospital, with the intent of providing other institutions with general guidance and insight through our experience. Methods: In 2012, under the direction of the Department of Medicine of the Instituto Nacional de Enfermedades Neoplásicas, a multidisciplinary team composed of oncologists, nurses, pharmacists, and informatics engineers was formed to develop software for a CPOE for chemotherapy within a preexistent homegrown electronic medical record system in various phases. This included mapping and redesigning processes in an entirely electronic format, integrating the needs of the user for the development of electronic order sets, developing a checkpoint and a warning system to minimize prescription errors, and finally, training all the staff in implementation of the system. Results: A CPOE for outpatient chemotherapy was successfully implemented in 2016. We have successfully standardized 266 chemotherapy orders, including for both solid tumors and hematologic malignancies, on the basis of appropriate guidelines. The software is linked to laboratory results and allows entry of important details for the patient's safety, such as anthropometric information for an automatic dose calculation and ranges for safe prescription. In addition, it is linked to the nursing plan sheets. Finally, it is possible to assess and continuously monitor the complex process of chemotherapy prescription. Conclusion: This is the first report of implementation of a CPOE for chemotherapy in our region. The system was designed by a multidisciplinary team with its own resources. Our experience demonstrates the feasibility of computerizing the chemotherapy prescription process, constituting a tangible example for other institutions with potential impact on patient care.